Replace Pharmaceutical Patents Now

被引:0
作者
Earl L. Grinols
James W. Henderson
机构
[1] Baylor University,Department of Economics
来源
PharmacoEconomics | 2007年 / 25卷
关键词
Patent System; Intervention Principle; Marginal Cost Price; Monopoly Price; Economic Profit;
D O I
暂无
中图分类号
学科分类号
摘要
Pharmaceutical patents are anachronistic holdovers from an era in which modern economic understanding and tax tools were unavailable. Superior mechanisms lie somewhere between a first best pricing solution for the entire economy at one extreme and the current arrangements at the other. We discuss the economics of suggested alternatives and suggest that the intertemporal bounty is the best way to meet the multiple objectives of immediate distribution at marginal cost pricing of newly innovated patented drugs and easily administered, efficient inducement to continued innovation. The intertemporal bounty prevents the expansion of monopoly power resulting from co-pay or -insurance provisions common to modern prescription drug plans.
引用
收藏
页码:355 / 363
页数:8
相关论文
共 31 条
[1]  
Grabowski H(2002)Returns on research and development for the 1990s new drug introductions Pharmacoeconomics 20 11-29
[2]  
Vernon J(2003)The price of innovation: new estimates of drug development costs J Health Econ 22 292-306
[3]  
DiMasi JA(1998)Can patents deter innovation? The anticommons in biomedical research Science 280 698-701
[4]  
DiMasi JA(2002)The gene patent dilemma: balancing commercial incentives with health needs Hous J Health L Policy 2 65-106
[5]  
Hansen R(2003)Engaging facts and policy: a multi-institutional approach to patent system reform Columbia Law Rev 103 1035-1135
[6]  
Grabowski H(2006)The intervention principle Rev Int Econ 14 226-247
[7]  
Heller MA(1984)Cost reduction, competition, and industry performance Econometrica 52 101-121
[8]  
Eisenberg RS(1970)Optimal departures from marginal cost pricing Am Econ Rev 60 265-283
[9]  
Andrews LB(1927)A contribution to the theory of taxation Econ J 37 47-61
[10]  
Rai AK(1986)A new look at the patent system Am Econ Rev 76 199-202